- $48.68m
- $22.99m
- $85.58m
- 66
- 74
- 21
- 53
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 20-F | 20-F | 20-F | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 158 | 89.6 | 73.8 | 71.5 | 85.6 |
Cost of Revenue | |||||
Gross Profit | 64.9 | 28.3 | 21.8 | 32.5 | 42 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 153 | 153 | 120 | 90.7 | 83 |
Operating Profit | 5.51 | -63 | -45.9 | -19.2 | 2.59 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 5.26 | -63.2 | -46.1 | -19.8 | 2.52 |
Provision for Income Taxes | |||||
Net Income After Taxes | 5.21 | -63.4 | -46.3 | -19.9 | 2.45 |
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 5.21 | -63.4 | -46 | -19.9 | 2.81 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 2.37 | -64.7 | -46 | -19.9 | 2.81 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.007 | -0.25 | -0.161 | -0.064 | 0.007 |